Gland Pharma Limited Capital Reinvestment Ratio
Gland Pharma Limited capital reinvestment ratio. Gland Pharma Limited (GLAND) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs5.93 Billion) in capital expenditures (Rs1.94 Billion). Check Gland Pharma Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gland Pharma Limited (2017–2026)
Capital reinvestment ratio of Gland Pharma Limited from 2017 to 2026. This chart tracks Gland Pharma Limited's Capital Reinvestment Ratio across 10 annual periods. Also explore Gland Pharma Limited net asset momentum to track the company's year-over-year net asset growth rate.
Gland Pharma Limited Capital Reinvestment Ratio by Year (2017–2026)
Gland Pharma Limited capital reinvestment ratio by year from 2017 to 2026. For the full cash flow conversion analysis, see GLAND operating cash flow.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.40x | Rs12.31 Billion | Rs4.91 Billion | ▼ -5.2% |
| 2025 | 0.42x | Rs9.15 Billion | Rs3.85 Billion | ▲ +7.5% |
| 2024 | 0.39x | Rs9.97 Billion | Rs3.90 Billion | ▼ -36.2% |
| 2023 | 0.61x | Rs3.64 Billion | Rs2.23 Billion | ▼ -7.2% |
| 2022 | 0.66x | Rs7.91 Billion | Rs5.22 Billion | ▲ +74.6% |
| 2021 | 0.38x | Rs6.05 Billion | Rs2.29 Billion | ▲ +36.2% |
| 2020 | 0.28x | Rs7.01 Billion | Rs1.95 Billion | ▼ -62.1% |
| 2019 | 0.73x | Rs1.85 Billion | Rs1.36 Billion | ▲ +73.9% |
| 2018 | 0.42x | Rs2.02 Billion | Rs851.75 Million | ▲ +72.8% |
| 2017 | 0.24x | Rs4.76 Billion | Rs1.16 Billion | — |